Avant Bio
Venture capitalNew York · Seed–Growth · 7 people tracked
Also known as AVANT BIO LLC
Investment thesis
AVANT BIO invests at the intersection of novel therapeutics and advanced technologies, focusing on companies building Therapeutic Enabling Technologies, TechBio, and healthtech solutions. The firm believes technology breakthroughs combined with a deeper understanding of biology are creating major opportunities to accelerate the development of transformative therapies. It seeks high-potential companies that other funds overlook, leveraging insider access to mitigate investment risk, and partners closely with entrepreneurs to add value through connections, deep expertise, and long-term guidance drawn from 40+ years of experience.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's website & public directories
What they invest in
from 4 of 11 portfolio companiesBiotech ×2Healthtech ×2Medical Devices ×2AI & Machine Learning ×1Digital Health ×1New Materials ×1
HQs:United States×4Canada×1Germany×1
Investments · 11 tracked
founders shown can be your intro pathSeattle, US
Board seatDaniella Kranjac· per SEC Form D · $3M raise · filed Dec 2025
A stem cell tools and technology company providing standardized platforms to accelerate regenerative medicine development and clinical trials.
BiotechFrederick, US
Jon Rowley(Director)Timothy Kelly(Executive Officer, Director)Margot Connor(Executive Officer, Director)
BoardMartin Westberg(Director)Rob Carlson(Director)
Board seatDaniella Kranjac· per SEC Form D · $12M raise · filed Jul 2024
Colchester, US
Board seatDaniella Kranjac· per SEC Form D · $41M raise · filed Jun 2023
Ottawa
Board seatDaniella Kranjac· per SEC Form D · filed May 2024
Company advancing super-resolution microscopy; raised a Series B led by AVANT BIO.
PathPresenter is a digital pathology platform used for viewing, sharing, and managing pathology images in clinical, research, and educational settings.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Raj Singh(Founder)Rajendra Singh(Co-founder)Cory Batenchuk(Senior Vice President, Operations & Co-founder)KV Acharya(System Architect & Co-founder)Patrick Myles(Chief Executive Officer)
PL BioScience develops human platelet-based cell culture media that promote cell growth, used in biotechnology research and cell culture applications.
BiotechNew Materials
Dr. Hatim Hemeda(Founder & CEO)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Avant Bio invest at?
- Avant Bio invests at the Seed, Series A, Series B, Growth stages.
- What sectors does Avant Bio focus on?
- Avant Bio focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
- Where is Avant Bio located?
- Avant Bio is headquartered in New York, US.
- Does Avant Bio lead rounds?
- Yes, Avant Bio leads investment rounds.
Images
Co-investors · 4
Madrona Venture Group is an early-stage venture capital firm that backs founding teams at seed, early, and acceleration stages, primarily in Seattle, the Bay Area, and beyond.
SoftBank Vision Fund invests globally in AI-focused companies working to transform and create industries.
2048 Ventures is a thesis-driven early-stage venture capital firm based in New York and Boston that backs founders building future technologies.
Dimension is a multistage investment firm that partners with companies working at the intersection of science and compute.
Firms observed investing alongside Avant Bio, from public investor directories. Shared companies are the overlap with Avant Bio's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
Seventure Partners is a European venture capital firm investing across life sciences, digital technologies, sport and performance, and the blue economy.
Amplitude Ventures is a Canadian healthcare venture capital firm focused on precision medicine, founded by former BDC partners Dion Madsen and Jean-François Pariseau. BDC Capital is an investor in its Fund I.